Table 2.
Patient characteristics independently associated with MOUD*
| Covariate | AOR (95% CI) | p-value |
|---|---|---|
|
| ||
| Demographics | ||
|
| ||
| Age (per year) | 1.04 (1.01, 1.07) | 0.003 |
|
| ||
| BMI | 1.00 (0.98, 1.02) | 0.917 |
|
| ||
| Race/Ethnicity (vs. Non-Hispanic White) | ||
| Non-Hispanic Black | 1.35 (0.91, 1.99) | 0.135 |
| Hispanic | 1.22 (0.66, 2.28) | 0.529 |
| Other race/ethnicity | 1.07 (0.61, 1.89) | 0.806 |
|
| ||
| Female | 0.18 (0.02, 1.30) | 0.089 |
|
| ||
| Marital status (vs. married) | ||
| Single | 1.15 (0.74, 1.76) | 0.534 |
| Divorced/widowed | 1.06 (0.81, 1.38) | 0.688 |
|
| ||
| Homeless | 0.85 (0.61, 1.20) | 0.352 |
|
| ||
|
| ||
| Liver Disease Factors | ||
|
| ||
| Hepatitis C virus | 2.15 (1.37, 3.35) | 0.001 |
|
| ||
| Prior hepatic decompensation | 1.01 (0.69, 1.47) | 0.970 |
|
| ||
| Hepatocellular carcinoma | 1.30 (0.64, 2.62) | 0.471 |
|
| ||
| MELD (per point) | 1.00 (0.97, 1.03) | 0.882 |
|
| ||
| Prior hepatitis C treatment | 0.90 (0.48, 1.70) | 0.747 |
|
| ||
|
| ||
| Substance Use Disorders | ||
|
| ||
| Nicotine use disorder | 1.24 (0.92, 1.67) | 0.161 |
|
| ||
| Alcohol use disorder | 0.70 (0.52, 0.95) | 0.020 |
|
| ||
| Other substance use disorders | 1.47 (1.05, 2.04) | 0.024 |
|
| ||
|
| ||
| Other Comorbidities | ||
|
| ||
| Pain related diagnoses | 0.94 (0.69, 1.27) | 0.670 |
|
| ||
| Opioid prescription | 0.51 (0.38, 0.70) | <0.001 |
|
| ||
| Mood disorders | 0.98 (0.72, 1.35) | 0.918 |
|
| ||
| Anxiety disorders | 1.41 (1.01, 1.98) | 0.046 |
|
| ||
| Schizophrenia | 0.59 (0.37, 0.95) | 0.031 |
|
| ||
| Post-traumatic stress disorder | 0.80 (0.56, 1.14) | 0.217 |
|
| ||
| Charlson Comorbidity Index (per point) | 1.05 (0.93, 1.19) | 0.431 |
*
MOUD=Medication treatment for opioid use disorder; BMI=body mass index; MELD=model for end-stage liver disease; AOR=adjusted odds ratio; CI=confidence interval